DealHorizon - the faster, easier way to create and share business plans

Companies > Tocagen

Please log in to edit this profile

Elevator Pitch	San Diego's Tocagen, a biotech developing gene therapy treatments for terminal cancers, says it has raised nearly $7.8 million from 75 investors in a Series D round that began Feb. 2, according to a recent regulatory filing. Tocagen, which also...
Industry Focus	BioPharma
Category	Companies - Expansion Stage

Contact Information

	United States

Email	Please log in
Web	http://www.tocagen.com

Compete.com

Investment Rounds

Series D

Amount: $8,000,000

Closed: March 8, 2010

Click here for press release

Investors

Reputation

Be the first to recommend Tocagen! Log in

Data Sources

Public information, member edits, and the DealHorizon.com team.

Office Location

Statistics

Founded: Unknown [Edit]

Ownership: Private [Edit]

Revenue: Unknown [Edit]

Employees: Unknown [Edit]

Search Site

Edit/Update

Flag Abuse

Followers

Please log in
Note: Once associated with a listing, Executives are automatically included as followers of that listing. Listing creators are also automatically added as followers.